# Piramal Phytoca (NSE: PIRPHYTO) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/PIRPHYTO · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹21,083 Cr, it ranks 343rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was 0.0% in FY19.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹21,083 Cr |
| ROE | 0.0% (FY19) |
| ROCE | 29.5% (FY19) |
| Debt to equity | -0.53 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY19 | ₹25 Cr | −₹8 Cr |
| FY18 | ₹24 Cr | −₹22 Cr |
| FY17 | ₹4 Cr | ₹0 Cr |
| FY16 | ₹6 Cr | −₹3 Cr |
| FY15 | ₹5 Cr | −₹3 Cr |
| FY14 | ₹6 Cr | −₹4 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Neuland Laboratories](https://app.pivotnow.in/stock/NEULANDLAB) | ₹18,855.00 | ₹24,191 Cr | 66.3 | — |
| [Rubicon Research](https://app.pivotnow.in/stock/RUBICON) | ₹1,408.90 | ₹23,301 Cr | 92.3 | — |
| [Procter Gamble](https://app.pivotnow.in/stock/PGHH) | ₹6,856.00 | ₹22,255 Cr | 26 | — |
| [SAGILITY](https://app.pivotnow.in/stock/SAGILITY) | ₹44.78 | ₹20,963 Cr | 22.6 | — |
| [Granules India](https://app.pivotnow.in/stock/GRANULES) | ₹807.65 | ₹20,013 Cr | 33 | — |
| [Indraprastha](https://app.pivotnow.in/stock/IGL) | ₹141.87 | ₹19,862 Cr | 12.8 | — |

## Questions and answers

### What is the market cap of Piramal Phytoca?

Piramal Phytoca's market capitalisation is ₹21,083 Cr (₹21,083 Cr) at the 22 Oct 2026 close, ranking 343rd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Piramal Phytoca?

Return on equity was 0.0% in FY19 and return on capital employed was 29.5% in FY19 (standalone figures).

### Is Piramal Phytoca a debt-free company?

Piramal Phytoca is close to debt-free: its debt-to-equity ratio was -0.53 in FY19.

### Who are Piramal Phytoca's competitors?

The listed Pharma & Healthcare companies closest to Piramal Phytoca by market cap are Neuland Laboratories, Rubicon Research, Procter Gamble, SAGILITY, Granules India and Indraprastha.

### Is Piramal Phytoca a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Piramal Phytoca's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PIRPHYTO against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.